My watch list
my.chemeurope.com  
Login  

03-25-2010: Phenomenex Inc. announces a Chiral Screening Service for customers in pharmaceutical and natural products research and development. This free service provides target screening using a library of HPLC and SFC columns including the Phenomenex Lux polysaccharide-based offerings. After resolving the chiral compound, Phenomenex also produces method development and optimization for the service customer, all within 10 business days.

Enantiomers of chiral compounds may have different pharmacological effects in biological systems. Regulations require that enantiomers of all chiral drugs in development be screened separately on their pharmacodynamic and pharmacokinetic properties.

"Resolving chiral compounds is relatively difficult, and column selection can be complicated," explained Kari Carlson, brand manager for Phenomenex. "Our Chiral Screening Service eliminates time-consuming guesswork and also gives customers a chance to 'test-drive' our Lux columns."

Watchlist

This is where you can add this news to your personal favourites

Facts, background information, dossiers
  • Phenomenex
  • target screening
  • SFC columns
More about Phenomenex
  • News

    Phenomenex Opens New Office in India

    Phenomenex Inc. announced that it has expanded its international subsidiary network to serve India directly from a new office in Hyderabad.  The new entity, which opened this month, will serve research communities throughout India with sales and service teams that sell all Phenomenex produc ... more

    Phenomenex President and CEO Fasha Mahjoor Named Finalist for Ernst & Young Entrepreneur of the Year 2010 Awards

    Phenomenex announced that president and CEO Fasha Mahjoor has been selected as a finalist for Ernst & Young's Greater Los Angeles Entrepreneur of the Year 2010 award. According to Ernst & Young LLP, the awards program recognizes entrepreneurs who demonstrate extraordinary success in the ar ... more

    Phenomenex Launches Chiral Screening Service

    Phenomenex Inc. announces a Chiral Screening Service for customers in pharmaceutical and natural products research and development. This free service provides target screening using a library of HPLC and SFC columns including the Phenomenex Lux polysaccharide-based offerings. After resolv ... more

  • Products

    Kinetex® Columns provide UHPLC Performance on any LC-System

    Kinetex HPLC/UHPLC columns improve sensitivity, shorten run times, and increase the sample throughput for your methods more

  • Companies

    Phenomenex Ltd.

    Phenomenex is a global technology leader committed to developing novel analytical chemistry solutions. These solutions help researchers in industrial, government and academic laboratories to solve their daily analytical challenges. Our solutions for Reversed Phase HPLC user include Kinetex® ... more

    Phenomenex Inc.

    Founded in 1982, Phenomenex is dedicated to the development, manufacturing and supply of key products used in the analysis and purification of chemicals and biochemicals. more

    Phenomenex B.V.

    Phenomenex, founded in 1982, is a global technology leader and innovator in the development of separation, purification and analytical chemistry solutions for life science, environmental, chemical manufacturing and related applications. Phenomenex products help customers streamline laborat ... more

Most read news
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE